Emergency Splenectomy in a Patient with Splenic Marginal Zone Lymphoma, Acute Portal Vein Thrombosis, and Chronic Viral Hepatitis B
Authors:
- Radmila KarpovaRKRadmila Karpova
- Andrey GorbunovAGAndrey Gorbunov
- Marina MnatsakanyanMMMarina Mnatsakanyan
- Aleksandr PogromovAPAleksandr Pogromov
- Irina SokolovaISIrina Sokolova
- Yuliya ShumskayaYSYuliya Shumskaya
- Ksenia RusskovaKRKsenia Russkova
- Kirill ChernousovKCKirill Chernousov
- Daria MomatyukDMDaria Momatyuk
Open Access
- 1 June 2021
- journal article
- case report
- Published by Taylor & Francis in Journal of Blood Medicine
- Vol. ume 12, 431-434
Abstract
Splenic marginal zone lymphoma (SMZL) is a type of non-Hodgkin’s lymphoma (NL) that occurs in 2 out of 100 cases and is more common in women aged > 60 years. A sluggish, asymptomatic course of the disease does not exclude transformation into a malignant form that occurs in 25% of patients with SMZL. Another equally important sign of an NL is thrombosis that occurs in 3.6% to 17.1% of the cases. In this report, we present a case of emergency splenectomy in a patient owing to difficulties in the diagnosis of SMZL, rapid onset of acute portal vein thrombosis, and the fulminant enlargement of the spleen accompanied by an increased risk of its rupture. Chronic hepatitis B was likely the trigger for transformation of the disease to an aggressive course. Portal vein thrombosis and the aggressive course of SMZL with rapid enlargement of the spleen and threat of its rupture in the background of viral hepatitis B required emergency splenectomy followed by anticoagulant, antiviral, and antitumor therapy.Keywords
This publication has 13 references indexed in Scilit:
- Marginal zone lymphomas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-upAnnals of Oncology, 2020
- Risk of venous thromboembolism in patients with non‐Hodgkin lymphoma surviving blood or marrow transplantationCancer, 2019
- VENOUS THROMBOSIS IN CHILDREN, ADOLESCENTS AND YOUNG ADULTS WITH LYMPHOMAS: INCIDENCE, CHARACTERISTICS, RISK FACTORS AND PROGNOSTIC VALUEOncohematology, 2018
- Distinct clinical characteristics draw a new prognostic model for splenic marginal zone lymphoma in HBV high prevalent regionOncotarget, 2017
- Prevalence of hepatitis B and hepatitis C viral infections in various subtypes of B-cell non-Hodgkin lymphoma: confirmation of the association with splenic marginal zone lymphomaBlood Cancer Journal, 2017
- Splenic marginal zone lymphoma: from genetics to managementBlood, 2016
- Association of Lymphomagenesis and the Reactivation of Hepatitis B Virus in Non-Hodgkin LymphomaCancer Control, 2015
- Lymphoma and venous thromboembolism: influence on mortalityThrombosis Research, 2014
- Incidence of non-Hodgkin's lymphoma among individuals with chronic hepatitis B virus infectionHepatology, 2007
- Splenic marginal zone lymphoma, iliac vein thrombosis, and monoclonal immunoglobulin Mκ antiphospholipid antibody with Annexin A5 interactionLeukemia & Lymphoma, 2006